1. Novartis to pay $678 to settle kickback claims — PhRMA sues Minnesota over insulin pricing law — Amgen Enbrel patents to be upheld through 2029 — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Do you have 7 minutes to fill out a quick survey about ordering food for work? You’ll be entered into a raffle to win a $100 Amazon.com gift card as a thank you for your time. click here
    Dismiss Notice

Redness Relief & Peels

Discussion in 'SkinMedica' started by Anonymous, Feb 16, 2012 at 4:02 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    You will never compete with the redness relief products from real pharma companies or even Skinceuticals. Your new peel is burning peoples faces really badly in some cases and is going to be shelved. You are overselling offices with all these rediculous promotions that never end and change like the wind. Too confusing and unorganized. Mega returns will be coming.
     

  2. Anonymous

    Anonymous Guest

    Skniceuticals sucks and we have a good pipeline, scar product and a hydroquinone alternative. Does anyone know when these are going to launch? Is the hydroquinone going to be an Rx? If so we better make sure we get coverage and if not will it really work? Can't wait to go public - big bucks for all
     
  3. Anonymous

    Anonymous Guest

    We're going to go public because of a hydroquinone substitute? And another scar product? I think you might need to go back to business school and forget the crap you learned at make up school sweetheart. Or better yet, just stop posting bimbonic comments that make us all look bad. Thank you.
     
  4. Anonymous

    Anonymous Guest

    Excited for the launches, great products for my customers. When will our new hydroquinone replacement launch?
     
  5. Anonymous

    Anonymous Guest

    More accurately, you're excited for the LUNCHES!!
     
  6. Anonymous

    Anonymous Guest

    Galderma is launching a prescription "anti-redness" product. It is a full NDA for the reduction of erythema associated with rosacea but the final results won't be ready until June 2012 Managed care is going to cover this drug at Tier 3 with an average copay of $55. They/we are going to also have a copay reduction program so patients have to pay no more than $10 for their prescription. You have about a year to try to get patients to pay out of pocket for your product. Please build up that market for us!
     
  7. Anonymous

    Anonymous Guest

    kd